Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27Kip1 ubiquitination in vitro

Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27(Kip1) ubiquitination in vitro

Novel NF-κB inhibitor

Potent and selective nociceptin opioid receptor (NOP) agonist

Potent CDC25A>Cdc25A inhibitor; Vitamine K3 analogue

Toxitant of Saccharomyces_cerevisiae>Saccharomyces cerevisiae

IκBα phosphorylation inhibitor

Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein

Novel dual inhibitor of viral and Streptococcus pneumoniae neuraminidase

Novel selective non-zinc-binding MMP-2 inhibitor

Novel inhibitor of ABCG2 transporter function

Novel DNA repair inhibitor

Novel activator of lanthionine synthetase C-like 2 (LANCL2), down-modulating pulmonary inflammation through the downregulation of TNF-α and MCP-1 and reduction in the infiltration of neutrophils, accelerating recovery and inducing IL-10-mediated regulator

Novel efflux pump inhibitor (EPI)

Novel non-peptide disruptor of IKKß/NEMO complex

Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines

Novel antagonist of the Grb7 SH2 domain; Antitumor Agent

Novel specific inhibitor of EGF receptor autophosphorylation and cell proliferation in HeLa cells by disrupting allosteric activation of EGF-stimulated dimer

Novel antagonist of the Grb7 SH2 domain; Antitumor Agent

Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein

Potent apoptosis inducer in pancreatic cancer cells

Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity

DT-diaphorase inhibitor

Selective potentiator at GluN1/GluN2C and GluN1/GluN2D receptors

Novel potent Mycobacterium tuberculosis DHFR inhibitor

Potent inhibitor of the AcrAB-TolC efflux pump in Escherichia coli, potentiating the antibacterial activities of novobiocin and erythromycin upon binding to the membrane fusion protein AcrA

Novel selective inhibitor of TET1 transcription and 5-hydroxymethylcytosine (5hmC) modification, effectively inhibiting cell viability in AML with high expression of TET1

Novel inhibitor of Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations

Novel potent gonist of Human G Protein-Coupled Receptor-35 (hGPR35) (EC50 8 nM)

Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity